Just another manipulative scare tactic that I wouldn't be surprised if they use against LifeMD next. Also, apparently, most of the patients in the study were outside of the U.S. SALT LAKE CITY, Jan. 21, 2021 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK), (" CleanSpark, or "the . Is This Warren Buffett Stock a Buy After Its Dividend Boost? Link to CULPER RESEARCH https://img1.wsimg.com/blobby/go/cc91fda7-4669-. When typing in this field, a list of search results will appear and be automatically updated as you type. The report lists numerous ethical, integrity, and past performance issues with the key personnel running the company. Honestly, we are letting them win with this plummeting over-reaction. This drop over the last month or so has torched like 9% of my portfolio, real quick. For more information, visit https://ATL-DATA.com. Has anyone attempted to recalculate their marketing cost per website visitor for LFMD vs HIMS. Press question mark to learn the rest of the keyboard shortcuts. For example, on April 11 Veru announced its Covid-19 drug brought down the mortality rate by 55% but the Culper report said that this was a manipulation of how high mortality rates were with Covid-19. As we all learned today, Culper and its shady supporters aim to create a veil of legitimate entities conducting research which just so happens to uncover some form of fraud/scandal/etc. This cant be right ? At just 150 patients, the trial is a . That's what happened to the shorts in the Gamestopfrenzy earlier this year. Veru has a market capitalization of $750 million at $8.46 as of May 6. In a 10-tweet thread digesting the report and posted on Monday, Culper accused Veru of "glaring anomalies" in its phase 3 clinical trial of coronavirus drug sabizabulin. However, the only problem is that there is a research report dated May 2 from a short-seller firm, Culper Research. For that matter, changing the name of your company a week before a short attack might make people nervous, too. These statements are based on CleanSpark's current beliefs and expectations. In the tweet thread, Culper wrote that "Veru's top ranks harbor a history of alleged sham science, failure, and misrepresentation" and are "a team of alleged frauds and failures who now tout a COVID-19 drug.". Capacity is expected to increase to over 300 PH/s in mining capacity by early 2021. Investors might want to watch out. They short the company, post these reports, and reap the benefits of people over reacting. 1001 and 1030). In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any information on this site. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. The suit's defamation claims center on a Culper report and 'investor alerts' accusing LifeMD principals of engaging in fraud at a previous company and using unlicensed doctors to dispense . CleanSpark Investigates Anonymous Short Seller. The Motley Fool has a disclosure policy. He was the original owner of Roe Tavern in Setauket,N.Y. You further agree to do your own research and due diligence, consult your own financial, legal, and tax advisors before making any . It is our view that the Oklahoma revenue opportunity is just 1/28 th (1.6MM/45MM) of or 96% lower than what Berman intimated during the investor presentation.. REKR's first quarter 2021 earnings corroborate our view. "We believe that the Company has vastly exaggerated the size of its EV charging network in order to siphon money from the pockets of investors to insiders. Contact Us| Yes, the two executives were at Redwood Scientific. On the other hand, shorts are always future buyers of your stock. To make the world smarter, happier, and richer. To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. | Learn more about Christian Lamarco's work experience, education, connections & more by visiting their profile on LinkedIn Is this happening to you frequently? Sometimes when there is "blood in the water" other shorts will jump in as well. As we all learned today, Culper and its shady supporters aim to create a veil of legitimate entities conducting research which just so happens to uncover some form of fraud/scandal/etc. Only bright sides I can see are that none of the allegations suggest that the revenue is fake, so were still talking about a company poised to do $90M in rev this year, and that management will know theyre under a microscope and should be incentivized to clean up their act. Veru (VERU -35.98%) has found itself the target of a short-seller, and as a result the biotech company's shares took a more than 12% hit on an otherwise upbeat Monday for the wider stock market. What should investors make of the allegations brought forth by Culper Research? To make the world smarter, happier, and richer. So let's take a look at what Culper is saying about Aterian. Blink claims that 'EV drivers can easily charge at any of its 15,000 charging stations,' but we estimate the Companys functional public charging station network consists of just 2,192 stations, a mere 15% of this claim.". Note: We do not offer technical support for developing or debugging scripted downloading processes. Picture this: Benedict Arnold, one of the United State's (U.S.) most infamous traitors and John Andre are successful in conspiring to attack West Point in 1780 ("The Culper Spy Ring," 2010). This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website. Making the world smarter, happier, and richer. And 9380 has actually been buying more stock in Aterian since it was acquired by the company. We scour the stock universe for good ideas and specialize in the technology and healthcare sectors, and in special situations in all sectors. On July 21, 2022, shares of Energy Vault fell over 6% after Culper Research issued a report that calls into serious question the business and operations of the company. Following publication of any research, we intend to continue transacting in the securities covered herein, and we may be long, short, or neutral at any time hereafter regardless of our initial recommendation, conclusions, or opinions. Article printed from InvestorPlace Media, https://investorplace.com/2022/05/veru-stock-could-face-difficulties-if-the-culper-research-report-is-true/. 2) In April, $VERU announced Phase III results (without full data) of sabizabulin (VERU-111) in hospitalized COVID-19 patients. About Us| Growing Mineola firm with national practice seeks associate (with 3-6 years experience) to handle complex general liability matters.Competit CASH KRUGLER & FREDERICKS LLC is Celebrating Our 20th Anniversary & Newest Partners! Investors could turn away from the company in droves if the researcher's allegations have merit, however. License our industry-leading legal content to extend your thought leadership and build your brand. I'm hoping one of you all much smarter people could help here and maybe start to connect some of these dots to pull down the veil a bit from these shady scumbags. Buy These 2 Stocks in 2023 and Hold for the Next Decade, Warren Buffett's Latest $2.9 Billion Buy Brings His Total Investment in This Stock to $66 Billion in 4 Years, 2 Stocks That Are About to Make Their Shareholders Richer, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Copyright, Trademark and Patent Information. The publisher of this false . Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. Since RexMD's founding, sales and marketing have ballooned to $20.0M in Q4 2020. A quick scroll through Culper's website yields very little in the way of personnel or address. It is very clear that one of their tactics is to submit FOIA requests for information regarding investigations into companies they are attacking, which if you know the Freedom of Information Act, is information that would never be released to the public. best hunting game for oculus quest 2 culper research legit. Veru(NASDAQ:VERU) is set to discuss on May 10 with the Food and Drug Administration a pre-Emergency Use Authorization (EUA) meeting for its Phase 3 Covid-19 drug, sabizabulin (VERU-111). The industry-leading media platform offering competitive intelligence to prepare for today and anticipate opportunities for future success. This response seems to concede that the company acquired the business from somebody convicted of crimes ("we identified the historical legal concerns raised in the report"), but that it judged the information irrelevant ("unrelated to the acquired businesses"). 1-2, 13). Invest better with The Motley Fool. The apparent purpose of the Culper Research "report" is to cover or profit from the publisher's short positions in the Company, which the publisher expressly acknowledges holding in the report itself. Will Aterian stock recover from this short attack? It stinks like a skunk to me, but Im not smart. Also, did you notice that there are now at least half a dozen law firms trolling for members to a class action lawsuit against Life? Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team. Culper Research, an activist short-seller that in its words "seek[s] to expose companies which have misrepresented their operations, failed to disclose significant risks, misappropriated capital . Published on June 1, 2022 June 3, 2022. Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users. I need to wait for management's response and the Q1 earnings release to really make an opinion on the merits of this short report. I like pain so I'm holding and also bought 400 more shares at $9, sitting at 2,000 shares now with a $16 cost basis, plus August calls with $15 strike that I bought just before market close yesterday. By the end of December, when Core filed for Chapter 11 bankruptcy, the firm's stock had plummeted by more than 98%.. This implies that it could end up wasting a lot of its cash if the Phase 3 clinical study is not successful in obtaining FDA EUA approval. Tickets are limited. The company generated about $23,100 in revenue for the first half of 2021. The Culper Spy Ring was assembled in 1778 by Major Benjamin Tallmadge (alias, John Bolton/721) at the request of General George Washington (711) and operated on Long Island (728) and New York City (727) during the . To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. If you can't trust management, or its numbers, you really shouldn't be in a stock. SALT LAKE CITY, Jan. 21, 2021 /PRNewswire/ --CleanSpark, Inc. (Nasdaq: CLSK), ("CleanSpark, or "the Company"), an advanced software and controls technology solutions company focused on solving modern energy challenges, has become aware of a report making false accusations against CleanSpark and its officers. To hide from slander cases, perhaps?). CleanSpark Investigating Short Seller Culper Research. The Culper Spy Rings was a spy network started by George Washington to get information about the British, during the Revolutionary War. Jan 21, 2021 1:53PM EST. By downloading from or viewing material on this website you agree to the following Terms of Service. to two felons and two alleged scam artists, all of whom will be free to dump their stock by August. In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any information on this site. Getting The Talent Balance Right: From Layoffs to Laterals to Mergers, How Can Firms Staff for Success? CleanSpark takes seriously any accusations of impropriety, stands behind its prior statements and disclosures, and will not tolerate unfounded and reckless claims against the Company. All expressions of opinion are subject to change without notice, and Culper does not undertake to update or supplement this report or any of the information contained herein. According to documents Aterian filed with the SEC on April 29, 9380 Macarthur does indeed own almost 5 million shares, or 16.2% of the company. LexisNexis and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. Im holding on to see the company response. However, the language in the response letter uses terms like "we are withholding documents that may be responsive" which Culper and co. are using to lead investors to the conclusion that such records do in fact exist and that an investigation into likely what Culper just detailed in their "report" is ongoing. The complaint, over an alleged short-and-distort stock scheme, was filed by Gordon Rees Scully Mansukhani on behalf of LifeMD Inc., CEO Justin Schreiber and CTO Stefan Galluppi. I think the only scary about the report is that some executives at LifeMD, used to work at Redwood Scientific, which was shut down by FTC upon fraud. The Patriots (colonists) were fighting against the British, in this war. CleanSpark has retained the law firm of Wilk Auslander LLP in connection with this matter and will be vigilant in investigating the sources of these misrepresentations, including the identity of those veiled behind the entity calling itself Culper Research. Nevertheless, if somehow the FDA does give its Covid-19 vaccine a EUA, all bets are off on the stock. That request was submitted in December 2020 and according to the SEC FOIA request logs, was done so by a Jeff Bourland linkedin on behalf of an unknown entity, perhaps the "Family Office" listed on his Linkedin. Use of Culper Research's("Culper") research is at your own risk. The suits defamation claims center on a Culper report and investor alerts accusing LifeMD principals of engaging in fraud at a previous company and using unlicensed doctors to dispense medications. $10/person - Space is limited. Culper has no identity other than a webpage, with no information (no address, about us, anything - wonder why the anonymity? To other RS execs were laundering money (husband and wife). You should assume that Culper (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a position in any securities covered herein. To put bluntly the research report implies that Verus Phase 3 study is not likely to succeed in helping VERU-111 obtain a EUA. Prosper Junior Bakiny has no position in any of the stocks mentioned. In addition, these transactions were structured as asset purchases only and therefore the founders did not become employees of Aterian. Research is not investment advice nor a recommendation or solicitation to buy securities. Meanwhile, almost six months after the acquisition, the audit has finally been completed, and Aterian finally filed its (late) numbers with the SEC on May 14. Core Scientific (NASDAQ: CORZ) fell 3.8% after a new short report from Culper Research. LFMD responded to short report, denying the claims and will report something in detail soon. ET after the short-selling group Culper Research published a new report criticizing the company's latest clinical trial . "We believe that the Company has . Invest better with The Motley Fool. Please disable your ad-blocker and refresh. Toggle Navigation Hindenburg Research. Five days later, the short report came public. More recently, Culper tweeted the response from SEC on a FOIA request for records pertaining to any investigations into OrthoPediatrics Corp., $KIDS. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Also he was allowed to treat patients via telehealth telehealth while on probation (src). 10 czerwca 2022 Federal Judge: Lancaster Investment Firm, Executives Must Pay $2M in Civil Penalties, Restitution, Special Master in MoneyGram Feud at SCOTUS Has Surprise Change of Mind, In Jackson's First Majority Opinion, SCOTUS Curbs Delaware's Collection of Unclaimed Property, Class Action Accusing BOA of Inadequate Notice Before Reposessions Hits Federal Court, Law.com Editors and Analysts Offer Top Trends to Watch for 2023. The SEC logs have not been posted yet for March 2021 requests, but I will update that once they become available. What kind of manipulation and block trades? Dynamically explore and compare data on law firms, companies, individual lawyers, and industry trends. Yes, it's horrible and I don't know what to do now. Cost basis and return based on previous market day close. With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. Culper alleges that Core Scientific "wildly oversold" both its mining and hosting business. Will Be Even Bigger Than Your Wildest Expectation, 7 Over-$100 Stocks That Are Worth Every Penny, Louis Navellier and the InvestorPlace Research Staff, 5 Penny Cryptos With the Most Potential for Growth, 7 Penny Stocks Poised for Explosive Growth in 2023. Taylor Carmichael has no position in any of the stocks mentioned. We look for stocks with the potential for big moves in the near future up or down. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Other than that, Culper is a shady short seller that attacks stock on fire with high retail investor base to panic them. For some reason, Jacob appears to be very opposed to crypto which may tie in to Culper's short attacks on $SOS, but that is pure speculation on my part. Yes and no. But they were not involved in any fraudulent activity. In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any . On October 31, 2019, Culper Research published a scathing report detailing reasons Culper Research believes the Company's internal review "was a farce, and shares are ultimately worthless." Treace Medical Concepts (TMCI) dropped 17% after a new short report from Culper Research.Culper Research says it's short the stock.Treace Medical (TMCI) didn't immediately return. The publication of the report and the tweet thread come hot on the heels of the news that the Food and Drug Administration (FDA) has set a pre-Emergency Use Authorization (EUA) meeting date to discuss that phase 3 study data. 1125 N. Charles St, Baltimore, MD 21201. Alpilean creator (Zach Miller) and medical research editor (Dr. Matthew Gibbs) medically concluded that the longest-lived people on the planet use a "secret trick" on the Alpine ice every night. The Austin-based company went public on the Nasdaq via a special purpose acquisition vehicle, or SPAC, in January 2022. Between the Hindenburg "Report" (a series of tweets), some firm called Culper Research (who seems to have a mediocre track record), and multiple YouTube videos, investors have a lot to consider. To make the world smarter, happier, and richer. Theres even room for more lines. Guys, this is a classic short attack. Dont listen to shitron in the first place, that guy is the worst, Did some research, seems like Dr Badii is no longer with RexMD. Actual results may differ from those set forth in this press release due to the risk and uncertainties inherent in our business, including, without limitation: the successful deployment energy solution on the project, the fitness of our energy software and solutions for this particular application or market, the expectations of future revenue growth may not be realized, ongoing demand for our software products and related services, the impact of global pandemics (including COVID-19) on the demand for our products and services; and other risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading "Risk Factors" in our Annual Report on Form 10-K and any subsequent filings with the SEC. The Motley Fool has no position in any of the stocks mentioned. Press question mark to learn the rest of the keyboard shortcuts. Research is not investment advice nor a recommendation or solicitation to buy securities. Such statements, estimates, projections and opinionsmay prove to be substantially inaccurate and are inherently subject to significant risks and uncertaintiesbeyond Culper's control. We have a suite of software solutions that provide end-to-end microgrid energy modeling, energy market communications, and energy management solutions. The Patriots hoped to gain freedom from Britain, liberty, and equality by winning the war. But there are some warning signs here. Thissuit was surfacedby Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Following publication of any research, we intend to continue transacting in the securities covered herein, and we may be long, short, or neutral at any time hereafter regardless of our initial recommendation, conclusions, or opinions. Thank you for your interest in the U.S. Securities and Exchange Commission. 831 Words4 Pages. However, such information is presented as is, without warranty of any kind whether express or implied. Holders of short positions trade on an expected decline in the price of a stock. You agree that regardless of any statute or law to the contrary, any claim or cause of action arising out of or related to use of this website or the material herein must be filed within one (1) year after such claim or cause of action arose or be forever barred. Another bright side is the short report does not have a single mention of PDFSimpli, so if all else fails and the telehealth biz goes to zero at least we have a market cap base of maybe $60-70 million for PDFSimpli lol. Create an account to follow your favorite communities and start taking part in conversations. Both options are priced the same. Time to Buy? That's $100 million you paid. Although we identified the historical legal concerns raised in the report, they were unrelated to the acquired businesses. I guess my last point is - how much of yesterday's decline is attributed to a short report from a company with a terrible track record vs. attributed to why the stock has declined between the earnings and short report? lifeguard air ambulance new mexico hassan has plastic surgery hassan has plastic surgery The allegations the firm makes are of a nature that most potential investors in Veru stock are likely to read. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas. The problem is it has just $116.1 million in cash as of Dec. 31 and is burning . In reality, they are simply conspiring to drive down the prices of stocks they take short positions in. Among its raft of accusations, Culper wrote that the trial is significantly smaller than those conducted for other COVID drug candidates and demonstrated a worryingly high mortality rate. If you have an ad-blocker enabled you may be blocked from proceeding. Just went through LifeMD's annual report and they don't break down marketing expenses per business line. Aterian issued a press release to respond to the short attack. culper research legitsan juan airport restaurants hours. Learn More. The report seems to imply that Veru will be another failure just like other drug companies the management has run. Women, Influence & Power in Law UK Awards 2023, Legalweek Leaders in Tech Law Awards 2023, WORKERS COMPENSATION ATTORNEY - Hartford, CT, Offering an Opportunity of a Lifetime for Personal Injury Lawyers, What Does Your Business Agreement Really Mean?